Health and Fitness Health and Fitness
Wed, March 7, 2012
[ Wed, Mar 07th 2012 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Announces I .. vices, Inc. in Connection with the Sale of the Co
[ Wed, Mar 07th 2012 ] - Market Wire
Sana Kliniken AG sigla contratto con Masimo che c .. reti di enti ospedalieri privati in Germania di a
[ Wed, Mar 07th 2012 ] - Market Wire
InfuSystem Postpones Announcement of Fourth Quarter and Fiscal Year 2011 Earnings
[ Wed, Mar 07th 2012 ] - Market Wire
Sana Kliniken AG signe un accord avec Masimo, don .. eaux hospitaliers privs d'Allemagne l'accs aux so
[ Wed, Mar 07th 2012 ] - Market Wire
Neurocrine Biosciences to Present at The 24th Annual Roth Conference
[ Wed, Mar 07th 2012 ] - Market Wire
ADVENTRX Reports Fourth Quarter and Full Year 2011 Financial Results
[ Wed, Mar 07th 2012 ] - Market Wire
Alexza and Grupo Ferrer Amend Adasuvea" Partnership
[ Wed, Mar 07th 2012 ] - Market Wire
Sequenom, Inc. Reports Financial Results for the Fourth Quarter and Full-Year of 2011
[ Wed, Mar 07th 2012 ] - Market Wire
Amylin Pharmaceuticals Announces Public Offering of Common Stock
[ Wed, Mar 07th 2012 ] - Market Wire
The Medicines Company to Participate in the 2012 Barclays Capital Global Healthcare Conference
[ Wed, Mar 07th 2012 ] - Market Wire
Halozyme Therapeutics to Present at Two Upcoming Investor Conferences in March
[ Wed, Mar 07th 2012 ] - Market Wire
Resmed Inc. to Present at Upcoming Conferences
[ Wed, Mar 07th 2012 ] - Market Wire
Quest Diagnostics to Speak at the 2012 Barclays Capital Global Healthcare Conference
[ Wed, Mar 07th 2012 ] - Market Wire
Sana Kliniken AG unterzeichnet Vertrag mit Masimo .. n Krankenhausnetzwerke Deutschlands so Zugriff au
[ Wed, Mar 07th 2012 ] - Market Wire
Harwood Feffer LLP Announces Investigation of Transcend Services, Inc.
[ Wed, Mar 07th 2012 ] - Market Wire
ThermoGenesis Announces Webcast of Presentation at Roth Capital Conference
[ Wed, Mar 07th 2012 ] - Market Wire
International Drug &;; Explosives Detec .. ounces Strategic Alliance With an American Compan
[ Wed, Mar 07th 2012 ] - Market Wire
CytoSorbents to Exhibit and Host Research Symposi .. m at Major International Critical Care Conference
[ Wed, Mar 07th 2012 ] - Market Wire
SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease
[ Wed, Mar 07th 2012 ] - Market Wire
Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial
[ Wed, Mar 07th 2012 ] - Market Wire
Prana Doses First Patient in the "IMAGINE" Phase II Alzheimer's Disease Trial
[ Wed, Mar 07th 2012 ] - Market Wire
GenVec to Release Fourth Quarter and Year-End 201 .. s and Conduct a Conference Call on March 15, 2012
[ Wed, Mar 07th 2012 ] - Market Wire
Immunovaccine Raises CAN$2.8M in Non-Brokered Private Placement
[ Wed, Mar 07th 2012 ] - Market Wire
Boehringer Ingelheim and Lilly's new oral type 2 .. , Jentaduetoa" (linagliptin/metformin hydrochlori
[ Wed, Mar 07th 2012 ] - Market Wire
EnteroMedics to Present at the 24th Annual ROTH Capital Growth Conference
[ Wed, Mar 07th 2012 ] - Market Wire
Isis Initiates Phase 1 Study in Patients With Can .. First Generation 2.5 Antisense Drug, ISIS-STAT3Rx
[ Wed, Mar 07th 2012 ] - Market Wire
Discovery Labs to Hold Conference Call to Discuss FDA Approval of SURFAXIN (lucinactant)
[ Wed, Mar 07th 2012 ] - Market Wire
Transcept Pharmaceuticals to Report Fourth Quarte .. l Results and Host Conference Call on March 14, 2
[ Wed, Mar 07th 2012 ] - Market Wire
Synthetic Biologics to Present at ROTH Annual Growth Stock Conference
[ Wed, Mar 07th 2012 ] - Market Wire
Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference

Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference


Published on 2012-03-07 04:36:59 - Market Wire
  Print publication without navigation


Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth... -- CRANBURY, N.J., March 7, 2012 /PRNewswire/ --

Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference

[ ]

CRANBURY, N.J., March 7, 2012 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: [ PTN ]) announced that it will be presenting at the 24th Annual ROTH OC Growth Stock Conference on Tuesday, March 13, 2012, at 1:30 p.m. Pacific Time.  The conference will be held at the Ritz Carlton Laguna Niguel in Dana Point, CA.

Carl Spana, Ph.D., President and Chief Executive Officer of Palatin Technologies, will provide an update on Palatin's corporate and development programs. A live audio broadcast will be available on the "Investors" section of Palatin's website at [ www.palatin.com ]. The live audio broadcast will be available through March 20, 2012.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor- specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin's website at [ www.palatin.com ].

SOURCE Palatin Technologies, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.palatin.com ]

Contributing Sources